Filing Flows › Jaguar Health (JAGX) › Q1 2026 › vs Q4 2025
Jaguar Health (JAGX) Q1 2026 vs Q4 2025 (quarter over quarter)
Jaguar Health's revenue rose $17.0M (+527%) from $3.2M in Q4 2025 to $20.3M in Q1 2026. Operating margin 50.2% against -656.6% (+706.9 pts).
Jaguar Health, Q1 2026: revenue $20.3M (+816% year over year), operating margin 50.2%, net earnings $8.7M, operating cash flow $8.8M. The chart draws each line against Q4 2025, the increases inside each band.
Margins
| Q1 2026 | Q4 2025 | Change | |
|---|---|---|---|
| Operating margin | 50.2% | -656.6% | +706.9 pts |
| Net margin | 43.0% | -716.9% | +760.0 pts |
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $20.3M | $3.2M | $17.0M | +527% |
| Operating profit | $10.2M | −$21.2M | $31.4M | — |
| Costs & expenses | $10.1M | $24.5M | −$14.4M | -59% |
| Pre-tax earnings | $8.7M | −$23.2M | $31.9M | — |
| Other expense, net | $1.5M | $2.0M | −$492K | -25% |
| Cost of revenue | $1.2M | $2.2M | −$1.0M | -47% |
| Research & development | $3.9M | $14.3M | −$10.4M | -73% |
| Sales & marketing | $896K | $2.3M | −$1.4M | -61% |
| General & admin | $4.1M | $4.9M | −$778K | -16% |
| Net earnings | $8.7M | −$23.2M | $31.9M | — |
| Depreciation & amortization | $473K | $477K | −$4K | -0.8% |
| Share-based compensation | $155K | $116K | $39K | +34% |
| Working capital & other | $521K | −$17.1M | $17.6M | — |
| Operating cash flow | $8.8M | −$5.5M | $14.3M | — |
Questions
How much did Jaguar Health's revenue grow quarter over quarter in Q1 2026?
Jaguar Health's revenue rose $17.0M (+527%) from $3.2M in Q4 2025 to $20.3M in Q1 2026. Operating margin 50.2% against -656.6% (+706.9 pts).